Declines in Human Papillomavirus (HPV)–Associated High-Grade Cervical Lesions After Introduction of HPV Vaccines in Connecticut, United States, 2008–2015 | Zendy

Linda M. Niccolai | Zendy; James Meek | Zendy; Monica Brackney | Zendy; James L. Hadler | Zendy; Lynn Sosa | Zendy; Daniel M. Weinberger | Zendy

Open Access

Declines in Human Papillomavirus (HPV)–Associated High-Grade Cervical Lesions After Introduction of HPV Vaccines in Connecticut, United States, 2008–2015

Author(s) -

Linda M. Niccolai,

James Meek,

Monica Brackney,

James L. Hadler,

Lynn Sosa,

Daniel M. Weinberger

Publication year - 2017

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cix455

Subject(s) - medicine , cervical cancer , cervical intraepithelial neoplasia , demography , cohort , gynecology , epidemiology , hpv vaccines , obstetrics , vaccination , cervical screening , hpv infection , cancer , immunology , sociology

Trends in human papillomavirus (HPV)-associated cervical lesions can provide an indication of vaccine impact. Our purpose was to measure trends in cervical lesions during 2008-2015 and to consider possible explanations including vaccination coverage, changes in screening for cervical cancer, and risk behaviors for acquiring HPV.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research